What is AlgiSys?
Founded in 2009 by Mr. LoPresti and Dr. Roe, AlgiSys is dedicated to commercializing over a decade of extensive algae research. Headquartered in Cleveland, Ohio, the company operates within the burgeoning biotechnology sector, aiming to leverage its scientific foundation for market-ready solutions. The company's focus on algae research positions it at the intersection of sustainable technology and advanced biological applications.
How much funding has AlgiSys raised?
AlgiSys has raised a total of $51.4M across 3 funding rounds:
Angel/Seed
$200K
Series A
$6.2M
Series B
$45M
Angel/Seed (2011): $200K, investors not publicly disclosed
Series A (2013): $6.2M, investors not publicly disclosed
Series B (2021): $45M supported by Peakstone Securities
What's next for AlgiSys?
The recent major strategic investment signals a pivotal growth phase for AlgiSys. This substantial backing is expected to accelerate the company's commercialization efforts, potentially expanding its research and development capabilities and market reach. As AlgiSys moves forward, its strategic financing will likely fuel advancements in its core algae-based technologies, positioning it for significant impact within the biotechnology landscape.
See full AlgiSys company page
